SCH-50911,分子式C8H15NO3,是一種γ-氨基丁酸β受體(GABAB選擇性拮抗劑[1],用於治療酒精戒斷症候群中的震顫性譫妄而開發[2]

SCH-50911
IUPAC名
2-[(2S)-5,5-Dimethylmorpholin-2-yl]acetic acid
識別
CAS號 160415-07-6  checkY
PubChem 5311429
ChemSpider 4470917
SMILES
 
  • O=C(O)C[C@@H]1OCC(NC1)(C)C
InChI
 
  • 1/C8H15NO3/c1-8(2)5-12-6(4-9-8)3-7(10)11/h6,9H,3-5H2,1-2H3,(H,10,11)/t6-/m0/s1
InChIKey SEYCKMQSPUVYEF-LURJTMIEBV
MeSH SCH-50911
IUPHAR配體 1075
性質
化學式 C8H15NO3
摩爾質量 173.21 g·mol⁻¹
熔點 154.5-157 °C(428-430 K)(鹽酸鹽)
若非註明,所有數據均出自標準狀態(25 ℃,100 kPa)下。

參考文獻

  1. ^ Blythin DJ, Kuo SC, Shue HJ, McPhail AT, Chapman RW, Kreutner W, et al. Substituted morpholine-2S-acetic acid derivatives: Sch 50911 and related compounds as novel GABAB antagonists.. Bioorganic & Medicinal Chemistry Letters. July 1996, 6 (13): 1529–34. doi:10.1016/S0960-894X(96)00267-3. 
  2. ^ Quang LS, Colombo G, Lobina C, Maccioni P, Orru A, Gessa GL, et al. Evaluation for the withdrawal syndrome from gamma-hydroxybutyric acid (GHB), gamma-butyrolactone (GBL), and 1,4-butanediol (1,4-BD) in different rat lines. Annals of the New York Academy of Sciences. August 2006, 1074: 545–58. PMID 17105952. doi:10.1196/annals.1369.055.